Efficacy of online cognitive behavioral therapy on symptoms and quality of life with irritable bowel syndrome.

Efficacy of online cognitive behavioral therapy on symptoms and quality of life with irritable bowel syndrome. - Online CGT for IBS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON48448

Enrollment

Registered

2019-10-18

Start date

2019-09-30

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel

Interventions

The treatment group receives an online CGT-treatment, based on mindfulness- and exposure-exercises, with a duration of ten weeks and consisting of five steps. The last step (exposure) takes six week

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * 18 years and over * IBS diagnosed by general practitioner or physician, meeting the Rome-IV-criteria * Having access to internet, a tablet/computer/laptop/telephone * Proficient in the Dutch language

Exclusion criteria

Exclusion criteria: * Medical intervention for IBS started in the 6 months preceding CBT Six months or less started with another (medical) intervention for IBS * Already, for any reason, in concurrent psychological treatment * Bowel disease other than IBS

Design outcomes

Secondary

Measure	Time frame
IBS-quality of life, as measured with the Irritable Bowel Syndrome-Quality of Life Measure (IBS-QOL), developed by Patrick, Drossman, Frederick, Dicesare en Puder (1998). Gastrointestinal specific anxiety (GSA), as measured with the Visceral Sensitivity Index (VSI), developed by Labus, Bolus, Chang, Wiklund, Naesdal, Mayer en Naliboff (2004). Patient demographics: gender, age, education, years and months since debut IBS-symptoms and diagnosed IBS, treatment history, medical health. Treatment expectation (one question), treatment and therapist satisfaction, suggestions for improving the treatment. Participants who decide to stop the treatment, will be asked for what reason.	—

Measure

Time frame

IBS-quality of life, as measured with the Irritable Bowel Syndrome-Quality of Life Measure (IBS-QOL), developed by Patrick, Drossman, Frederick, Dicesare en Puder (1998). Gastrointestinal specific anxiety (GSA), as measured with the Visceral Sensitivity Index (VSI), developed by Labus, Bolus, Chang, Wiklund, Naesdal, Mayer en Naliboff (2004). Patient demographics: gender, age, education, years and months since debut IBS-symptoms and diagnosed IBS, treatment history, medical health. Treatment expectation (one question), treatment and therapist satisfaction, suggestions for improving the treatment. Participants who decide to stop the treatment, will be asked for what reason.

—

Primary

Measure	Time frame
IBS-symptoms The primary outcome of this study is IBS-symptoms, as measured with the Irritable Bowel Severity Scoring System (IBS-SSS), developed by Francis, Morris and Whorwell (1997).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)